Two Sigma Advisers
IBRX icon

Two Sigma Advisers’s ImmunityBio IBRX Stock Holding History

Two Sigma Advisers’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,142,256
Closed -$2.26M – 1016
2025
Q4 		$2.26M Buy
1,142,256
+1,024,600
+871% +$2.32M ﹤0.01% 1138
2025
Q3 		$289K Buy
+117,656
New +$303K ﹤0.01% 2004
2022
Q3 		– Sell
-15,200
Closed -$57K – 2638
2022
Q2 		$57K Sell
15,200
-8,200
-35% -$32.9K ﹤0.01% 2463
2022
Q1 		$131K Sell
23,400
-4,700
-17% -$28.8K ﹤0.01% 2457
2021
Q4 		$171K Buy
+28,100
New +$211K ﹤0.01% 2321
2020
Q4 		– Sell
-429,233
Closed -$2.98M – 2477
2020
Q3 		$2.98M Buy
+429,233
New +$4.28M 0.01% 962

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return